The Huntington Disease Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat Huntington Disease, a rare, inherited neurological disorder that causes the progressive breakdown of nerve cells in the brain. Symptoms of the disease include involuntary movements, cognitive decline, and psychiatric disturbances. Currently, there is no cure for Huntington Disease, but medications can help manage symptoms and slow the progression of the disease. The Huntington Disease Drug market is composed of both branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they may offer more effective symptom management. The market is highly competitive, with many companies vying for market share. Some companies in the Huntington Disease Drug market include AbbVie, Teva Pharmaceuticals, and Lundbeck. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
